---
title: "Tigermed plans to sell Frontage's overseas laboratory business to Charles River, Song Li"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/304988489.md"
description: "Tigermed plans to privatize its controlled subsidiary Frontage Holdings. The restructuring involves selling Frontage's overseas laboratory business to Charles River Laboratories and Chairman Song Li, while retaining the China business. This move aims to sharpen Tigermed's focus on clinical contract research services and optimize resource allocation, expected to generate proceeds and investment gains for Tigermed."
datetime: "2026-11-10T09:53:59.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/304988489.md)
  - [en](https://longbridge.com/en/news/304988489.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/304988489.md)
generator: "portal-rs"
---

# Tigermed plans to sell Frontage's overseas laboratory business to Charles River, Song Li

-   Tigermed proposes to participate in the privatization of controlled subsidiary Frontage Holdings through wholly owned Hongkong Tigermed. \* Subsequent restructuring would sell Frontage’s overseas laboratory services business to Charles River Laboratories, Frontage Chairman Song Li and his trusts. \* Frontage’s China business would be retained, supporting a sharper focus on clinical contract research services and more efficient resource allocation. \* The transactions are expected to generate proceeds and investment gains for Tigermed, which acquired control of Frontage in 2014. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hangzhou Tigermed Consulting Co. Ltd. published the original content used to generate this news brief via PR Newswire (Ref. ID: CN93812) on November 10, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [CRL.US](https://longbridge.com/en/quote/CRL.US.md)
- [01521.HK](https://longbridge.com/en/quote/01521.HK.md)
- [03347.HK](https://longbridge.com/en/quote/03347.HK.md)
- [300347.CN](https://longbridge.com/en/quote/300347.CN.md)

## Related News & Research

- [Hangzhou Tigermed releases audited data for Frontage privatization and separation deal](https://longbridge.com/en/news/305814363.md)
- [Tigermed Issues Progress Update on Frontage Holdings Transactions](https://longbridge.com/en/news/305815201.md)
- [Hangzhou Tigermed Announces Extraordinary General Meeting](https://longbridge.com/en/news/305816569.md)
- [Hangzhou Tigermed Files HKEX Next-Day Disclosure Return Announcing Share Buyback](https://longbridge.com/en/news/306242433.md)
- [Hangzhou Tigermed Discloses Share Buyback in HKEX Next-Day Return](https://longbridge.com/en/news/305942742.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**